Edgewise Therapeutics Inc (EWTX) Insider Trading
- $26,345,942.54
- $15,004,710.63
- Sept. 23, 2024
- Alan J Russell
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 23, 2024 | General Counsel | 20,922 | $27.63 | Sell | $578,074.86 | |
Sept. 20, 2024 | CFO | 125,092 | $28.57 | Sell | $3,573,878.44 | |
Sept. 20, 2024 | Insider | 75,000 | $28.27 | Sell | $2,120,250.00 | |
Sept. 20, 2024 | CMO | 7,162 | $28.29 | Sell | $202,612.98 | |
Sept. 20, 2024 | General Counsel | 50,000 | $28.37 | Sell | $1,418,500.00 | |
May 2, 2024 | CEO | 3,152 | $18.91 | Sell | $59,604.32 | |
May 2, 2024 | Insider | 1,718 | $18.91 | Sell | $32,487.38 | |
May 2, 2024 | CMO | 3,682 | $18.91 | Sell | $69,626.62 | |
May 2, 2024 | General Counsel | 1,956 | $18.91 | Sell | $36,987.96 | |
May 2, 2024 | CFO | 2,157 | $18.91 | Sell | $40,788.87 | |
Feb. 9, 2024 | General Counsel | 8,029 | $20.01 | Sell | $160,660.29 | |
Feb. 8, 2024 | Insider | 4,600 | $20.01 | Sell | $92,046.00 | |
Feb. 7, 2024 | General Counsel | 17,993 | $20.00 | Sell | $359,860.00 | |
Jan. 23, 2024 | CFO | 90,000 | $15.78 | Sell | $1,420,200.00 | |
Jan. 23, 2024 | Director | 454,545 | $11.00 | Buy | $4,999,995.00 | |
Dec. 27, 2023 | General Counsel | 8,497 | $10.50 | Sell | $89,218.50 | |
Dec. 26, 2023 | Insider | 172,585 | $9.33 | Sell | $1,610,218.05 | |
Dec. 26, 2023 | Director | 10,857 | $9.30 | Buy | $100,970.10 | |
May 2, 2023 | CFO | 1,336 | $8.90 | Sell | $11,890.40 | |
May 2, 2023 | CMO | 3,254 | $8.90 | Sell | $28,960.60 | |
May 2, 2023 | Insider | 1,747 | $8.90 | Sell | $15,548.30 | |
May 2, 2023 | General Counsel | 1,897 | $8.90 | Sell | $16,883.30 | |
May 2, 2023 | CEO | 3,203 | $8.90 | Sell | $28,506.70 | |
Oct. 3, 2022 | General Counsel | 4,730 | $9.76 | Sell | $46,164.80 | |
Sept. 16, 2022 | Director | 484,496 | $10.32 | Buy | $4,999,998.72 | |
Sept. 14, 2022 | Major Shareholder | 484,496 | $10.32 | Buy | $4,999,998.72 | |
Aug. 3, 2022 | General Counsel | 9,232 | $9.31 | Sell | $85,949.92 | |
July 5, 2022 | General Counsel | 8,186 | $8.35 | Sell | $68,353.10 | |
June 21, 2022 | General Counsel | 31,078 | $7.29 | Sell | $226,558.62 | |
June 17, 2022 | General Counsel | 22,127 | $6.62 | Sell | $146,480.74 | |
June 14, 2022 | General Counsel | 3,628 | $6.02 | Sell | $21,840.56 | |
June 10, 2022 | General Counsel | 7,125 | $6.05 | Sell | $43,106.25 | |
June 7, 2022 | General Counsel | 18,123 | $6.61 | Sell | $119,793.03 | |
June 3, 2022 | General Counsel | 15,230 | $6.05 | Sell | $92,141.50 | |
May 18, 2022 | Director | 138,000 | $7.21 | Buy | $994,980.00 | |
May 16, 2022 | General Counsel | 10,800 | $7.42 | Sell | $80,136.00 | |
Nov. 8, 2021 | Insider | 9,017 | $20.16 | Sell | $181,782.72 | |
Nov. 5, 2021 | Insider | 13,042 | $19.62 | Sell | $255,884.04 | |
Nov. 3, 2021 | Insider | 26,184 | $18.18 | Sell | $476,025.12 | |
Nov. 1, 2021 | Insider | 469 | $18.02 | Sell | $8,451.38 | |
Oct. 14, 2021 | Insider | 5,749 | $18.18 | Sell | $104,516.82 | |
Oct. 11, 2021 | Insider | 1,270 | $18.02 | Sell | $22,885.40 | |
Oct. 8, 2021 | Insider | 5,902 | $18.15 | Sell | $107,121.30 | |
Oct. 6, 2021 | Insider | 2,108 | $18.03 | Sell | $38,007.24 | |
Oct. 4, 2021 | Insider | 100 | $18.00 | Sell | $1,800.00 | |
Oct. 1, 2021 | Insider | 274 | $18.00 | Sell | $4,932.00 | |
Sept. 29, 2021 | Insider | 11,844 | $16.86 | Sell | $199,689.84 | |
Sept. 27, 2021 | Insider | 11,611 | $17.98 | Sell | $208,765.78 | |
Sept. 23, 2021 | Insider | 26,835 | $18.54 | Sell | $497,520.90 | |
March 30, 2021 | Director | 15,625 | $16.00 | Buy | $250,000.00 |
Insiders are both buying and selling Edgewise Therapeutics Inc stock.
The insider traders at Edgewise Therapeutics Inc are: Alan J Russell, John R Moore, R Michael Carruthers, John R. Moore, Joanne M Donovan, Behrad Derakhshan, Kevin Koch, Peter A Thompson, Jonathan D Root, Holdings A/S Novo, Jonathan C Fox, James E Flynn, and Orbimed Advisors Llc
The most active insider trader at Edgewise Therapeutics Inc is Alan J Russell with 15 trades.
R Michael Carruthers has sold the most Edgewise Therapeutics Inc stock with a total value of $8,620,636.15.
James E Flynn has bought the most Edgewise Therapeutics Inc stock with a total value of $20,000,000.00.
The most recent insider trade for Edgewise Therapeutics Inc was on Sept. 23, 2024.
The single biggest insider buy for Edgewise Therapeutics Inc was from James E Flynn with a total value of $10,000,000.00 on March 30, 2021.
The single biggest insider sell for Edgewise Therapeutics Inc was from R Michael Carruthers with a total value of $3,573,878.44 on Sept. 20, 2024.